Kyungnam to expand its presence in placenta injection market
Published: 2011-01-31 06:56:00
Updated: 2011-01-31 06:56:00
Kyungnam Pharmaceutical Co. said Thursday that it will go all-out to promote the sales of its placenta injections in the domestic market as the Korean Food and Drug Administration certified the efficacy and safety of its placenta injections.
To this end, Kyungnam will release 240,000 placent...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
